UK Becomes First Country to Approve Gene Editing for Medical Treatment: CRISPR

The UK's MHRA approved Casgevy, the first gene therapy treatment for sickle cell disease. The United Kingdom's Medicines and Healthcare Regulatory Agency (MHRA) approved Casgevy, the first gene therapy treatment for sickle cell disease.

Related Keywords

Gatersleben ,Sachsen Anhalt ,Germany ,United Kingdom ,United States ,Helen Oneill ,Sean Gallup Getty ,Quincy Jon ,Vertex Pharmaceuticals Europe Ltd ,Crop Plant Research ,University College London ,Cnn ,Healthcare Regulatory Agency ,Leibnitz Institute Of Plant Genetics ,Drug Administration ,Tech Times ,Vertex Pharmaceuticals ,Nobel Prize ,Kingdom Becomes First Country ,Gene Editing ,Medical Treatment ,Getty Images ,Leibnitz Institute ,Plant Genetics ,Heleno Neill ,Know About Sickle Cell ,South Asian ,Southeast Asian ,Uk ,Health ,Enetics ,Rispr ,Sickle Cell Disease ,Thalessemia ,Hemoglobin ,